| |
|
2007
|
|
Top
|
|
Vol. 91
|
|
December 1 December 2007 No. 2-3, p107
|
|
November 2 November 2007 No. 1, p1
|
|
November, Supplement 1 November 2007,
|
|
Collaborative Injection Drug Users Study III/ Drug Users Intervention Trial
|
|
|
| |
|
Vol. 89
|
|
July 10 July 2007 No. 2-3, p107
|
|
June 15 June 2007 No. 1, p1
|
|
|
Vol. 88
|
|
May, Supplement 2 May 2007,
|
|
Customizing Treatment to the Patient: Adaptive Treatment Strategies
|
|
April 17 April 2007 No. 1, p1
|
|
April, Supplement 1 April 2007,
|
|
Psychiatric Predictors of Early Drug Use and Abuse
|
|
| |
|
Vol. 87
|
|
March 16 March 2007 No. 2-3, p107
|
|
February 23 February 2007 No. 1, p1
|
|
|
Vol. 86
|
|
January 12 January 2007 No. 2-3, p95
|
|
January 5 January 2007 No. 1, p1
|
|
|
2006
|
|
Top
|
|
|
|
| |
|
Vol. 83
|
|
July 27 July 2006 No. 3, p185
|
|
June 28 June 2006 No. 2, p95
|
|
June 9 June 2006 No. 1, p1
|
|
June, Supplement 1 June 2006,
|
|
Drug Formulation and Abuse Liability
|
|
|
Vol. 82
|
|
May 20 May 2006 No. 3, p185
|
|
April 28 April 2006 No. 2, p91
|
|
April, Supplement 1 April 2006,
|
|
Drug Abuse and HIV/AIDS: International Research Lessons and Imperatives
|
|
March 15 March 2006 No. 1, p1
|
|
| |
|
Vol. 81
|
|
February 28 February 2006 No. 3, p207
|
|
February 1 February 2006 No. 2, p103
|
|
January 4 January 2006 No. 1, p1
|
|
|
2005
|
|
Top
|
|
Vol. 80
|
|
December 12 December 2005 No. 3, p283
|
|
November 1 November 2005 No. 2, p147
|
|
October 1 October 2005 No. 1, p1
|
|
|
Vol. 79
|
|
September 1 September 2005 No. 3, p281
|
|
August 1 August 2005 No. 2, p119
|
|
July 1 July 2005 No. 1, p1
|
|
| |
|
Vol. 78
|
|
June 1 June 2005 No. 3, p233
|
|
May 9 May 2005 No. 2, p111
|
|
April 4 April 2005 No. 1, p1
|
|
|
Vol. 77
|
|
March 7 March 2005 No. 3, p213
|
|
February 14 February 2005 No. 2, p107
|
|
January 7 January 2005 No. 1, p1
|
|
|
2004
|
|
Top
|
|
|
|
Vol. 75
|
|
September 6 September 2004 No. 3, p225
|
|
August 16 August 2004 No. 2, p123
|
|
July 15 July 2004 No. 1, p1
|
|
| |
|
Vol. 74
|
|
June 11 June 2004 No. 3, p223
|
|
May 10 May 2004 No. 2, p115
|
|
April 9 April 2004 No. 1, p1
|
|
|
Vol. 73
|
|
March 8 March 2004 No. 3, p217
|
|
February 7 February 2004 No. 2, p109
|
|
January 7 January 2004 No. 1, p1
|
|
|
2003
|
|
Top
|
|
Vol. 72
|
|
December 11 December 2003 No. 3, p207
|
|
November 24 November 2003 No. 2, p99
|
|
October 24 October 2003 No. 1, p1
|
|
|
Vol. 71
|
|
September 10 September 2003 No. 3, p219
|
|
August 20 August 2003 No. 2, p109
|
|
July 20 July 2003 No. 1, p1
|
|
| |
|
Vol. 70
|
|
June, Supplement 5 June 2003 No. 3,
|
|
Abuse Liability Assessment on CNS Drugs
|
|
June 5 June 2003 No. 3, p223
|
|
May, Supplement 21 May 2003 No. 2,
|
|
Buprenorphine and Buprenorphine/Naloxone : A Guide For Clinicians
|
|
May 21 May 2003 No. 2, p117
|
|
May 1 May 2003 No. 1, p1
|
|
|
Vol. 69
|
|
April 1 April 2003 No. 3, p215
|
|
March 1 March 2003 No. 2, p109
|
|
January 24 January 2003 No. 1, p1
|
|
| |
|
|
